JOHNSON & JOHNSON (JNJ) Stock News
NYSE:JNJ - New York Stock Exchange, Inc. - US4781601046 - Common Stock - Currency: USD
JNJ Latest News, Press Relases and Analysis
Johnson & Johnson (NYSE:JNJ) - A Reliable Dividend Stock Worth Considering
Johnson & Johnson (NYSE:JNJ) is a top dividend stock with a 3.32% yield, strong profitability, and a reliable payout history, making it a solid choice for income investors.
Johnson & Johnson Is Great. Here's Why You Shouldn't Buy It.
Want Decades of Passive Income? 5 Stocks to Buy Now and Hold Forever
Forever is a tricky word in the stock market, but these stocks are as safe as they come and will pay you to hold them.
How Earle Dickson Healed Wound Care With The Band-Aid
When Earle Dickson (1892-1961) invented the Band-Aid, treatments for minor cuts and scrapes were dicey. He changed that.
Mentions: KUVE
Johnson & Johnson (JNJ) Launches Two New Plating Systems in the US
Johnson & Johnson (NYSE:JNJ) is one of the 10 Best and Cheap Stocks to Buy Now. On June 19, Johnson & Johnson (NYSE:JNJ) announced the launch of two new plating systems in the United States under its VOLT platform, called Distal Radius and Proximal Humerus 3.5 Plating Systems. The systems are designed to treat the two […]
J&J (JNJ) Faces $8M Verdict Over Talc Case; Stock Still Gains 4.66% YTD
Johnson & Johnson (NYSE:JNJ) is one of the 10 undervalued blue chip stocks analysts recommend for smart investing. On June 18, Dean Omar Branham Shirley, LLP, a Dallas, Texas-based law firm, announced an $8 million verdict against Johnson & Johnson in Suffolk County, Massachusetts. The verdict was awarded to Janice Paluzzi, an 84-year-old Massachusetts woman […]
IMAAVY™ (nipocalimab-aahu) showed greater sustained disease control versus approved FcRn blockers for generalized myasthenia gravis (gMG) at multiple timepoints over 24 weeks in newly published indirect treatment comparison (ITC)
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new data from an indirect treatment comparison (ITC) that showed consistent and sustained disease...
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
A heated debate over the U.S. healthcare system erupted on X, pitting billionaire entrepreneur Mark Cuban against Sen. Elizabeth Warren (D-Mass) over the root causes of soaring drug prices. What Happened: The clash, unfolding as of Friday, has ...
JNJ’s Consistent Payout Makes It a Top Pick for Down Markets
Johnson & Johnson (NYSE:JNJ) is among the best dividend stocks for a bear market. The company is facing a combination of slow revenue growth, unresolved legal battles over talc products, and looming drug price negotiations under new Medicare rules. These issues could weigh on investor sentiment and profitability in the near term. Despite current challenges, […]
Mentions: KVUE
Don't Overlook Jabil (JBL) Stock After Topping Its Q3 Expectations
Trading near 52-week highs of over $200 a share, Jabil (JBL) stock may be poised for more upside after posting strong results for its fiscal third quarter this week.
Move Over Hims & Hers Health: This Insurance Business Could Be the Next Monster Healthcare Stock (Hint: It's Not UnitedHealth)
Hims & Hers Health shares rocketed higher over the last year, rewarding investors.
Elizabeth Warren, Jan Schakowsky Reportedly Seek Answers From Pfizer, Amgen, And Others On Low Federal Tax Bills
The Democratic lawmakers alleged that pharmaceutical companies avoided paying U.S. tax bills by shifting their profits to offshore subsidiaries in jurisdictions with significantly lower tax rates, such as Ireland and Bermuda, according to CNBC.
Pharma manufacturing 'boom' faces high costs, potential delays
Here are Big Pharma's plans to reshore manufacturing amid cost and policy headwinds.
Investigational combination of first-in-class bispecifics TALVEY® and TECVAYLI® shows deep and durable responses in heavily pretreated multiple myeloma patients with extramedullary disease
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today new results from the Phase 2 RedirecTT-1 study evaluating the investigational combination of...
Johnson & Johnson CEO: 'We’re in the Golden Era of Medical Innovation'
Johnson & Johnson Chairman and CEO Joaquin Duato believes that we are now in a “golden era” of innovation, particularly in the United States. Venture capital plays a vital early-stage role, but big pharma provides the infrastructure and market access. We visit Johnson & Johnson's innovation facility in Spring House to see how its early-stage innovation ecosystem serves patients and the local economy. (Source: Bloomberg)
Mentions: F
Middle East Escalation, Lower Gas Prices, Johnson & Johnson, Flying Cars | Wall Street Week
This week, Richard Haass of Centerview Partners tells us what the escalation of geopolitical tension between Israel and Iran could mean for oil prices. And President Trump’s call for $2 gas may please consumers, but in oil towns like Odessa, falling prices threaten jobs, investment and the economic foundation of the US energy heartland. Plus, an interview with Johnson & Johnson’s CEO on the golden age of medical innovation. Later, will flying cars soon be a reality? (Source: Bloomberg)
UBS Backs Johnson & Johnson as a Defensive Play in Uncertain Times
Johnson & Johnson (NYSE:JNJ) is one of the best stocks for a retirement stock portfolio. On June 12, UBS global equity strategist Andrew Garthwaite’s team pointed to Johnson & Johnson as one of the top cyclical picks, excluding financials, whose performance tends to move with the broader economy. The stock has gained over 9% in […]
Longtime Dividend Giant Announces Hike
National Fuel Gas Company (NYSE:NFG) is one of the best stocks for a retirement stock portfolio. On June 12, the company declared a 3.9% hike in its quarterly dividend to $0.535 per share. Through this increase, the company stretched its dividend growth streak to 55 years. In addition to this strong dividend growth, National Fuel […]
Turkey Launches Antitrust Investigation into Coca-Cola Over Potential Competition Breach
The Coca-Cola Company (NYSE:KO) is one of the best stocks for a dividend stock portfolio. The Turkish Competition Board announced on Tuesday that it has launched a formal investigation into Coca-Cola to assess whether the company breached the country’s competition laws. According to the board’s statement, the probe follows preliminary findings suggesting The Coca-Cola Company […]
Johnson & Johnson's dual-targeting CAR T-cell therapy shows encouraging first results in large B-cell lymphoma
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) announced today the first clinical data from an ongoing Phase 1b study for JNJ-90014496 (JNJ-4496), an...
Kenvue mulls sale of some skin health and beauty brands, sources say
NEW YORK (Reuters) -Kenvue is exploring the sale of some of its skin health and beauty brands, four people familiar with the matter said on Thursday, as the consumer health firm prunes an underperforming business segment to focus on core products. The company, which was spun out of Johnson & Johnson in 2023, is zeroing in on smaller brands in the unit to sell such as Clean & Clear, Maui Moisture, Neostrata, its German baby care brand Bebe, and Japanese brand Dr.Ci:Labo, the sources said. It plans to hold onto the bigger names in the unit, such as Neutrogena and Aveeno, the sources said.
New results for Johnson & Johnson's bleximenib demonstrate promising antileukemic activity in combination with venetoclax and azacitidine for acute myeloid leukemia
/PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced new Phase 1b data showing encouraging antileukemic activity and a promising safety profile for...
Judge Orders J&J Subsidiary to Pay $442 Million in Antitrust Lawsuit
Johnson & Johnson (NYSE:JNJ) is one of the best Dow stocks to invest in. Recently, a federal judge ruled that a Johnson & Johnson subsidiary must pay $442 million in damages after a jury concluded last month that the company had broken antitrust laws by withholding support from hospitals that used reprocessed catheters. U.S. District […]
Jim Cramer Says Uber Technologies Stock “Goes Higher”
Uber Technologies, Inc. (NYSE:UBER) is one of the 15 stocks that Jim Cramer recently talked about. A caller mentioned that the people are worried about Uber Technologies, Inc.’s (NYSE:UBER) autonomous driving when they should not be, and Cramer commented: “I agree with you, especially with the setback of Elon. Look, I gotta tell you, I’m […]